Home › Myeloproliferative Neoplasms › Pennsylvania › Philadelphia
Myeloproliferative Neoplasms clinical trials in Philadelphia, PA
8 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
RecruitingPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RecruitingPhase 1/2
- University of Pennsylvania, Philadelphia
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Drexel University School of Medicine, Philadelphia
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- and 1 more
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Philadelphia
Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
RecruitingPhase 1
- Fox Chase Cancer Center - Philadelphia, Philadelphia
Myeloproliferative Neoplasms trials in other cities
- Houston, TX16 studies
- New York City, NY15 studies
- Boston, MA14 studies
- Milwaukee, WI10 studies
- Miami, FL10 studies
- Durham, NC9 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Chicago, IL9 studies
- Cleveland, OH8 studies
- Portland, OR8 studies
- Atlanta, GA8 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.